Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Related Party Transactions [Abstract] Related Party Transactions [Abstract] Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Total payments Total payments Long-Term Debt, Gross Maturity of short-term investments Proceeds from Maturities, Prepayments and Calls of Short-Term Investments Collaboration and license agreement, integrin research targets amount (up to) Collaboration And License Agreement Integrin Research Targets Amount Collaboration and license agreement integrin research targets amount. Entity Address, Postal Zip Code Entity Address, Postal Zip Code Debt Draw, Tranche Two Debt Draw, Tranche Two [Member] Debt Draw, Tranche Two Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding 2024 Long-Term Debt, Maturity, Year Two Tranche one amount undrawn Debt Instrument, Tranche One Amount Undrawn Debt Instrument, Tranche One Amount Undrawn Debt Instrument [Axis] Debt Instrument [Axis] Total property and equipment, gross Property, Plant and Equipment, Gross Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Summary of Money Market Funds, U.S. Government Agency Securities and Corporate Debt Securities by Significant Investment Category Cash, Cash Equivalents and Investments [Table Text Block] Reclassification of restricted stock awards from liabilities to common stock upon vesting Reclassification Of Restricted Stock Awards From Liabilities To Common Stock Upon Vesting Reclassification of restricted stock awards from liabilities to common stock upon vesting. Financial Instruments [Domain] Financial Instruments [Domain] Loan agreement interest rate Debt Instrument, Basis Spread on Variable Rate Payment of deferred offering costs Payments Of Deferred Offering Costs Represents the payments of deferred offering costs. Statistical Measurement Statistical Measurement [Domain] Research and Development [Abstract] Research and Development [Abstract] Indefinite-lived Intangible Assets, Major Class Name Indefinite-Lived Intangible Assets, Major Class Name [Domain] Depreciation expense Depreciation Proceeds from term loan Proceeds from Issuance of Debt Option exercises (in shares) Number of Options, Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Vesting of restricted stock awards (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures 2020 Stock Options And Incentive Plan Two Thousand And Twenty Stock Options And Incentive Plan [Member] 2020 Stock options and incentive plan. Prepaid licenses Prepaid Licenses, Current Prepaid Licenses, Current Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Underlying common stock fair value (USD per share) Underlying Common Stock Fair Value Underlying common stock fair value. Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Additional paid-in capital Additional Paid in Capital, Common Stock Valuation date share price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Other Other Noncash Income (Expense) Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Net loss Net loss Net Income (Loss) Attributable to Parent Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Summary of Black-Scholes Option Pricing Model to Estimate Stock-based Compensation Expense for 2020 Employee Stock Purchase Plan Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Potentially dilutive securities excluded from computation of diluted net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Incentive Stock Options and Nonqualified Stock Options Incentive Stock Options And Nonqualified Stock Options [Member] Incentive stock options and nonqualified stock options. Accretion of final payment Long-Term Debt, Accretion Of Final Payment Long-Term Debt, Accretion Of Final Payment Schedule of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Stock options and ESPP Employee Stock Option And Purchase Plan [Member] Employee stock option and purchase plan. Operating Lease Lessee, Operating Lease, Liability, to be Paid [Abstract] Prepaid insurance Prepaid Insurance Equity Component Equity Component [Domain] Fair Value Measurements, Non-recurring Basis Fair Value, Nonrecurring [Member] Earnings Per Share Reconciliation [Abstract] Earnings Per Share Reconciliation [Abstract] Correlation coefficient Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions ; Correlation Coefficient Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions ; Correlation Coefficient Assets measured at fair value Assets, Fair Value Disclosure Vesting rights, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Leases Lessee, Operating Leases [Text Block] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Related Party Related Party [Domain] Plan Name Plan Name [Axis] Market Value Debt Securities, Available-for-Sale Supplemental disclosures of noncash investing and financing activities: Supplemental Cash Flow Elements [Abstract] Weighted- Average Exercise Price per Share, Forfeited (USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Novartis Agreement Novartis Agreement [Member] Novartis agreement. Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Plan Name Plan Name [Domain] 2022 (remainder of the year) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Weighted- Average Remaining Contractual Term (in Years), Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Schedule of Weighted-average Remaining Lease Terms and Discount Rates Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee Award Type Award Type [Axis] Third Rock Ventures Third Rock Ventures [Member] Third Rock Ventures. Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Lease liabilities, current Total current operating lease liabilities Operating Lease, Liability, Current Related Party Transaction Related Party Transaction [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] License Agreements [Line Items] License Agreements [Line Items] License agreements. Number of Options, Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities Liabilities Novartis Agreement, R&D For Integrin Research Targets Novartis Agreement, R&D For Integrin Research Targets [Member] Novartis Agreement, R&D For Integrin Research Targets Weighted-average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Geographical Geographical [Axis] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Average peer group correlation coefficient Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions; Average Peer Group Correlation Coefficient Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions; Average Peer Group Correlation Coefficient Number of classes of stock authorized Number Of Classes Of Stock Authorized Number Of Classes Of Stock Authorized Common stock issued in a public offering, net of offering expenses Stock Issued During Period, Value, New Issues Vesting rights Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights Aggregate fair value of restricted stock awards vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Document Type Document Type Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Weighted-Average Grant Date fair value, Outstanding and unvested, beginning balance (USD per share) Weighted-Average Grant Date fair value, Outstanding and unvested, ending balance (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Debt Disclosure Debt Disclosure [Text Block] Product and Service Product and Service [Domain] Entity Shell Company Entity Shell Company Accrued liabilities Increase (Decrease) in Accrued Liabilities 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Financial Instrument [Axis] Financial Instrument [Axis] 2015 Equity and 2020 Incentive Plan Two Thousand Fifteen And Two Thousand Twenty Equity Incentive Plan [Member] Two thousand fifteen and two thousand twenty equity incentive plan . 2025 Long-Term Debt, Maturity, Year Three Document Period End Date Document Period End Date Interest receivable Interest Receivable, Current Grant date fair value of stock option Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value Share based compensation arrangement by share based payment award options grants in period fair value. Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Total assets Assets Debt Disclosure [Abstract] Net loss per share, attributable to common stockholders: Net loss per share attributable to common stockholders: Earnings Per Share [Abstract] Income Statement Location Income Statement Location [Axis] Redeemable Convertible Preferred Stock Redeemable Convertible Preferred Stock [Text Block] Redeemable convertible preferred stock. Antidilutive Securities Antidilutive Securities [Axis] Accrued liabilities (Note 6) Total accrued liabilities Accrued Liabilities, Current Net loss per share: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Weighted- Average Exercise Price per Share, Exercised (USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Forfeited (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Accrued compensation and benefits Employee-related Liabilities, Current Variable lease payments Variable Lease, Cost Stockholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Net Loss Per Share Attributable to Common Stockholders Earnings Per Share [Text Block] Regent of the University of California License Agreement (the "UC Agreement") License Agreements [Text Block] The entire disclosure of license agreements. Summary of Black-Scholes Option Pricing Model to Estimate Stock-based Compensation Expense for Stock Option Awards Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Base rent abated amount Base Rent Abated Amount Base rent abated amount. Operating lease liabilities Increase (Decrease) in Operating Lease Liability Related Party Transaction [Line Items] Related Party Transaction [Line Items] Award Type Award Type [Domain] Unrecognized compensation expense, weighted average period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted- Average Remaining Contractual Term (in Years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Tax credit receivable Income Taxes Receivable, Current Deferred offering costs in accounts payable and accrued liabilities Deferred Offering Costs In Accounts Payable And Accrued Liabilities Deferred Offering Costs In Accounts Payable And Accrued Liabilities Entity Registrant Name Entity Registrant Name Common stock issued in a public offering, net of offering expenses (in shares) Stock Issued During Period, Shares, New Issues Research and Development Arrangement, Contract to Perform for Others [Line Items] Research and Development Arrangement, Contract to Perform for Others [Line Items] Expected dividend Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Entity Address, City or Town Entity Address, City or Town Leases [Abstract] Leases [Abstract] Operating expenses: Operating Expenses [Abstract] Performance Stock Units Performance Stock Units [Member] Performance Stock Units Vesting of restricted stock awards Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Underwriters Underwriters [Member] Underwriters Minimum Minimum [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (USD per share) Common Stock, Par or Stated Value Per Share Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Financial Instruments Fair Value Disclosures [Text Block] Trading Symbol Trading Symbol Entity File Number Entity File Number Research and development Research and development expense Research and Development Expense Purchase of short-term investments Payments to Acquire Short-Term Investments Laboratory equipment Equipment [Member] Achievement of First Patient Dosing Milestone Achievement Of First Patient Dosing Milestone [Member] Achievement of first patient dosing milestone. Accrued research and development expenses Accrued Research And Development Expenses, Current Accrued research and development expenses, current Title of Individual Title of Individual [Axis] Number of shares granted during period (in shares) Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted stock units Restricted Stock Units (RSUs) [Member] Effective tax rate Effective Income Tax Rate Reconciliation, Percent Accrued Expenses and Other Liabilities Accrued Expenses And Other Liabilities [Member] Accrued expenses and other liabilities. Number of Options, Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Use of Estimates Use of Estimates, Policy [Policy Text Block] Amount available after tranche one Debt Instrument, Amount Available After Tranche One Debt Instrument, Amount Available After Tranche One Common stock, voting rights Common Stock, Voting Rights Accounts payable Increase (Decrease) in Accounts Payable Additional shares authorized for future grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Expected volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Income Taxes Income Tax Disclosure [Text Block] Revenue recognized from related party Revenue from Related Parties Supplemental disclosures of cash flow information: Supplemental Cash Flow Disclosures [Abstract] Supplemental Cash Flow Disclosures Abstract License Agreements [Table] License Agreements [Table] License agreements. Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Basic (USD per share) Earnings Per Share, Basic UC Regents U C Regents [Member] UC Regents. 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Novartis Novartis [Member] Novartis. Amount remaining for achievement Collaboration And License Agreement Integrin Research Targets Amount, Remaining Collaboration And License Agreement Integrin Research Targets Amount, Remaining Counterparty Name Counterparty Name [Domain] Indefinite-lived Intangible Assets Indefinite-Lived Intangible Assets [Axis] Total stockholders’ equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Weighted- Average Exercise Price per Share, Forfeited (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Entity Interactive Data Current Entity Interactive Data Current Initial public offering, shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Money Market Funds Money Market Funds [Member] Accumulated Deficit Retained Earnings [Member] Unrecognized compensation expense Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Common Stock Common Stock [Member] Percentage of payroll deductions Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Total other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Statement [Table] Statement [Table] Weighted-Average Grant Date fair value, Vested (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Effective interest rate for the term loan Debt Instrument, Interest Rate, Effective Percentage Lease term extension period Lessee, Operating Lease, Renewal Term Document Quarterly Report Document Quarterly Report Schedule of TSR PSU Valuation Assumptions Schedule of Share-Based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions [Table Text Block] Schedule of Share-Based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions Current assets Assets, Current [Abstract] Lease liabilities, non-current Total non-current operating lease liabilities Operating Lease, Liability, Noncurrent Payment made under defined contribution plan Defined Contribution Plan, Cost Statistical Measurement Statistical Measurement [Axis] Average peer group volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions; Average Peer Group Volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions; Average Peer Group Volatility Related Party Transaction Related Party Transaction [Axis] Leasehold improvements Leasehold Improvements [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Equity Components Equity Components [Axis] Fair Value, Recurring Fair Value, Recurring [Member] Weighted- Average Exercise Price per Share, Exercisable (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Related Party Transactions Related Party Transactions Disclosure [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Other accrued liabilities Accounts Payable and Other Accrued Liabilities, Current Outstanding and unvested, beginning balance (in shares) Outstanding and unvested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] California CALIFORNIA Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Weighted- Average Exercise Price per Share, Vested and expected to vest (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Document Transition Report Document Transition Report Local Phone Number Local Phone Number Summary of Option Activity Under the 2015 Plan and 2020 Plan Share-Based Payment Arrangement, Option, Activity [Table Text Block] Loss from operations Operating Income (Loss) Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Weighted-average common shares outstanding used to calculate net loss per share attributable to common stockholders: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Accrued expenses and other liabilities Deferred Compensation Share-Based Arrangements, Liability, Current Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Thereafter Long-Term Debt, Maturity, after Year Four Long-Term Debt, Maturity, after Year Four Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income tax provision Income Tax Expense (Benefit) Geographical Geographical [Domain] Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional Paid-In Capital Additional Paid-in Capital [Member] Balance Sheet Location Balance Sheet Location [Domain] License Agreements Licensing Agreements [Member] Document Fiscal Period Focus Document Fiscal Period Focus Period of base rent abatement Period Of Base Rent Abatement Period Of Base Rent Abatement Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Expected volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Less: Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Expected term (in years) Expected term of options (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Dividends paid (USD per share) Common Stock, Dividends, Per Share, Cash Paid Number of Integrin research targets Number Of Integrin Research Targets Number of Integrin research targets. Common stock, $0.0001 par value; 300,000,000 shares authorized at September 30, 2022 and December 31, 2021; and 48,749,842 and 36,083,301 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively; Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Shares of common stock available for future grants under the 2020 Equity Incentive Plan Two Thousand Twenty Equity Incentive Plan [Member] 2020 equity incentive plan. Weighted-Average Grant Date fair value, Issued (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Summary of Potentially Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Aggregate Intrinsic Value, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Term Loan Facility Term Loan Facility [Member] Term Loan Facility Current liabilities Liabilities, Current [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Net loss attributable to common stockholders Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted- Average Remaining Contractual Term (in Years), Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Leased premises under non cancelable operating lease Leased Space Under Non Cancellable Operating Lease Leased space under non cancellable operating lease. Purchase of property and equipment in accounts payable and accrued liabilities Capital Expenditures Incurred but Not yet Paid Income Statement Location Income Statement Location [Domain] Amendment Flag Amendment Flag Net cash (used in ) provided by investing activities Net Cash Provided by (Used in) Investing Activities Lease costs Operating Lease, Cost Term loan facility Debt Instrument, Face Amount Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Restricted stock awards granted and not purchased Restricted Stock Awards Granted And Not Purchased [Member] Restricted stock awards granted and not purchased. Construction-in-progress Construction in Progress [Member] Entity Current Reporting Status Entity Current Reporting Status Accrued Liabilities and Other Liabilities [Abstract] Accrued Liabilities and Other Liabilities [Abstract] Other non-current assets Other Assets, Noncurrent Target level of achievement percentage Share-Based Compensation Arrangement By Share-Based Payment Award, Target Level Of Achievement Percentage Share-Based Compensation Arrangement By Share-Based Payment Award, Target Level Of Achievement Percentage Number of Options, Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Refundable security deposit Security Deposit Adimab Agreement Adimab Agreement [Member] Adimab agreement. Lease term Lessee, Operating Lease, Term of Contract Counterparty Name Counterparty Name [Axis] Number of Options, Outstanding, Beginning balance (in shares) Number of Options, Outstanding, Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Cash and Cash Equivalents Cash and Cash Equivalents [Axis] Prepaid research and development Prepaid Research And Development, Current Prepaid Research And Development, Current Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Initial Public Offering IPO [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net Operating lease, payments Operating Lease, Payments Exercises of outstanding stock option awards Stock Options Share-Based Payment Arrangement, Option [Member] Other non-current assets Increase (Decrease) in Other Noncurrent Assets Title of Individual Title of Individual [Domain] Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Performance-based restricted stock units Performance-Based Restricted Stock Units [Member] Performance-Based Restricted Stock Units Option exercises Stock Issued During Period, Value, Stock Options Exercised Term loan Term loan Long-Term Debt Balance Sheet Location Balance Sheet Location [Axis] Debt Draw Period [Axis] Debt Draw Period [Axis] Debt Draw Period Share price of shares issued in initial public offering (USD per share) Sale of Stock, Price Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Total operating expenses Operating Expenses Maximum Maximum [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Unrealized Gains Debt Securities, Available-for-Sale, Unrealized Gain Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Novartis Agreement, R&D For PLN-1474 Novartis Agreement, R&D For PLN-1474 [Member] Novartis Agreement, R&D For PLN-1474 Total current assets Assets, Current Research and Development Arrangement, Contract to Perform for Others, Type Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Small Business Entity Small Business Measurement Frequency Measurement Frequency [Domain] Common Stock Stockholders' Equity Note Disclosure [Text Block] Non-cash operating lease expense Operating Lease, Right-of-Use Asset, Amortization Expense Number of common stock issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Dividends declared (USD per share) Common Stock, Dividends, Per Share, Declared Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Property and Equipment, net Property, Plant and Equipment Disclosure [Text Block] Debt Draw, Tranche One Debt Draw, Tranche One [Member] Debt Draw, Tranche One Aggregate Intrinsic Value, Outstanding balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Short-term investments Short-Term Investments Non-employee Director Nonemployee Director [Member] Nonemployee Director. Debt Instrument [Line Items] Debt Instrument [Line Items] Class of Stock [Line Items] Class of Stock [Line Items] Payment of debt issuance costs Payments of Debt Issuance Costs Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] U.S. Treasury securities included in cash and cash equivalents and short-term investments US Treasury Securities [Member] Defined Contribution Plan Defined Contribution Plan [Text Block] Weighted- Average Exercise Price per Share, Granted (USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Adjusted Cost Debt Securities, Available-for-Sale, Amortized Cost 2022 Long-Term Debt, Maturity, Remainder of Fiscal Year Shares used in computing net loss per share attributable to common stockholders: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Proceeds from the initial public offering Sale of Stock, Consideration Received on Transaction Accounts payable Accounts Payable, Current Comprehensive loss: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Aggregate Intrinsic Value, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Number of tranches Debt Instrument, Number Of Tranches Debt Instrument, Number Of Tranches 2026 Long-Term Debt, Maturity, Year Four Entity Filer Category Entity Filer Category Proceeds from issuances of common stock Proceeds from Issuance of Common Stock Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Milestone and annual royalty paid Milestone And Annual Royalty Paid Milestone and annual royalty paid. Total stock-based compensation expense Share-Based Payment Arrangement, Expense Security Exchange Name Security Exchange Name Weighted- Average Exercise Price per Share, Outstanding, Beginning balance (USD per share) Weighted- Average Exercise Price per Share, Outstanding, Ending balance (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Schedule of Shares Reserved for Future Issuance Schedule Of Common Stock Reserved For Future Issuance Table [Table Text Block] Schedule of common stock reserved for future issuance. Percent of estimated fair value of shares Share Based Compensation Arrangement By Share Based Payment Award Percent Of Estimated Fair Value Of Shares Share Based Compensation Arrangement By Share Based Payment Award Percent Of Estimated Fair Value Of Shares Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Unvested restricted shares Restricted Stock [Member] Employee stock purchase plan offering period Employee Stock Purchase Plan Offering Period Employee stock purchase plan offering period. Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] General and administrative expenses General and Administrative Expense [Member] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Debt Draw, Tranche Three Debt Draw, Tranche Three [Member] Debt Draw, Tranche Three Shares of common stock available for future issuance under the 2020 ESPP 2020 Employee Stock Purchase Plan Two Thousand And Twenty Employee Stock Purchase Plan [Member] Two thousand and twenty employee stock purchase plan. Options under plan may be granted for periods Share Based Compensation Options Under Plan May Be Granted For Periods Share based compensation options under plan may be granted for periods. Total shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Cover [Abstract] Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Computer equipment and software Computer Equipment And Software [Member] Computer equipment and software. Lease term extension notice period Lease Term Extension Notice Period Lease term extension notice period. Common stock shares outstanding percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Equity Incentive Plans and Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Summary of Components and Classification of Stock-based Compensation Expense for Stock-based Awards Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Risk free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Total liabilities and stockholders’ equity Liabilities and Equity Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Related Party Related Party [Axis] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Restricted stock awards Restricted Common Stock Awards [Member] Restricted common stock awards. Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Accrued Liabilities and Other Current Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Less: Present value discount Lessee, Operating Lease, Liability, Undiscounted Excess Amount Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Diluted Diluted (USD per share) Earnings Per Share, Diluted Sale of Stock Sale of Stock [Domain] Valuation allowance as a percentage on total deferred tax assets Valuation Allowance As Percentage On Deferred Tax Assets Valuation allowance as percentage on deferred tax assets. Temporary Equity Disclosure [Abstract] Temporary Equity Disclosure [Abstract] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Proceeds from upfront non-refundable license fee Proceeds From Upfront Non Refundable License Fee Proceeds from upfront non-refundable license fee. Total current liabilities Liabilities, Current Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Summary of Restricted Stock Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Expiration period from date of grant Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Due from related parties Due from Related Parties Corporate debt securities included in cash and cash equivalents and short-term investments Corporate Debt Securities [Member] Common stock fair market value percentage Common Stock Fair Market Value Percentage Common stock fair market value percentage . Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Schedule of Operating Lease Liability Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Exercise price as a percentage of estimated grant date fair value of shares Share Based Compensation Arrangement By Share Based Payment Award Exercise Price With Purchase Price Of Common Stock Percentage Of Estimated Grant Date Fair Value For Shareholders Share based compensation arrangement by share based payment award exercise price with purchase price of common stock percentage of estimated grant date fair value for shareholders. Net unrealized loss (gain) on short-term investments Unrealized Gain (Loss) on Investments Product and Service Product and Service [Axis] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Interest expense Interest Expense Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Net unrealized loss on short-term investments Net unrealized loss on short-term investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax U.S. government agency securities included in cash and cash equivalents and short-term investments US Government Corporations and Agencies Securities [Member] Transaction price of Novartis agreement Related Party Transaction, Amounts of Transaction Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Cash and Cash Equivalents Cash and Cash Equivalents [Domain] Equity [Abstract] Equity [Abstract] Debt Draw Period [Domain] Debt Draw Period [Domain] Debt Draw Period [Domain] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Entity Tax Identification Number Entity Tax Identification Number Shares authorized for future grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Less: unamortized debt issuance costs Unamortized Debt Issuance Expense Other Non-current Assets Other Noncurrent Assets [Member] Prepaid Expenses and Other Current Assets Prepaid Expenses And Other Current Assets [Text Block] Prepaid Expenses And Other Current Assets Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Measurement Frequency Measurement Frequency [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Novartis Collaboration and License Agreement ("the Novartis Agreement") Collaborative Arrangement Disclosure [Text Block] Loan Agreement Loan Agreement [Member] Loan Agreement City Area Code City Area Code General and administrative General and Administrative Expense Assets Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Sale of Stock Sale of Stock [Axis] 2015 Equity Incentive Plan Two Thousand Fifteen Equity Incentive Plan [Member] 2015 equity incentive plan. Other Other Prepaid Expense, Current Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Annual percentage increase to base rent Operating Lease, Annual Increase To Base Rent, Percent Operating Lease, Annual Increase To Base Rent, Percent Proceeds from sale of common stock in a public offering, net of expenses Proceeds from Issuance Initial Public Offering Liabilities measured at fair value Financial Liabilities Fair Value Disclosure 2023 Long-Term Debt, Maturity, Year One Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Contractual arrangements cancellation period Contractual Arrangements Cancellation Period Contractual arrangements cancellation period. Grant date fair value of stock option (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Variable Rate [Axis] Variable Rate [Axis] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Research and development expenses Research and Development Expense [Member] Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Interest and other income (expense), net Interest And Other Income, Net Interest And Other Income, Net Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Adimab Development and Option Agreement (the "Adimab Agreement") Research, Development, and Computer Software Disclosure [Text Block] License Agreements [Abstract] License Agreements [Abstract] License agreements. Organization and Description of Business Business Description and Basis of Presentation [Text Block] Schedule of Prepaid Expenses and Other Current Assets Schedule Of Prepaid Expenses And Other Current Assets [Table Text Block] Schedule Of Prepaid Expenses And Other Current Assets Payment received from related party Payment Received From Related Parties Payment Received From Related Parties